Publications



2017

Oertel F.C.; Zimmermann H.; Brandt A.U.; Paul F.
Optische Kohaerenztomographie bei Neuromyelitis optica-Spektrum-Erkrankungen [Optical coherence tomography in neuromyelitis optica spectrum disorders]
Nervenarzt : (2017-11-08)



Phillips O. R.; Joshi S.H.; Narr K.L.; Shattuck D.W.; Singh M.; Di Paola M.; Ploner C.J.; Pruess H.; Paul F.; Finke C.
Superficial white matter damage in anti-NMDA receptor encephalitis.
Journal of Neurology Neurosurgery and Psychiatry : (2017-11-03)



Heesen C.; Poettgen J.; Rahn A.C.; Liethmann K.; Kasper J.; Vahter L.; Drulovic J.; Van Nunen A.; Wilkie D.; Beckmann Y.; Paul F.; Koepke S.; Giordano A.; Solari A.
What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0)
Multiple Sclerosis and Related Disorders 18: 186-195 (2017-11)



Hoeltje M.; Mertens R.; Schou M.B.; Saether S.G.; Kochova E.; Jarius S.; Pruess H.; Komorowski L.; Probst C.; Paul F.; Bellmann-Strobl J.; Gitler D.; Benfenati F.; Piepgras J.; Ahnert-Hilger G.; Ruprecht K.
Synapsin-antibodies in psychiatric and neurological disorders: prevalence and clinical findings
Brain Behavior and Immunity 66: 125-134 (2017-11)



Klawiter E.C.; Bove R.; Elsone L.; Alvarez E.; Borisow N.; Cortez M.; Mateen F.; Mealy M.A.; Sorum J.; Mutch K.; Tobyne S.M.; Ruprecht K.; Buckle G.; Levy M.; Wingerchuk D.; Paul F.; Cross A.H.; Jacobs A.; Chitnis T.; Weinshenker B.
High risk of postpartum relapses in neuromyelitis optica spectrum disorder
Neurology : (2017-11-01)



Penner I.K.; Paul F.
Fatigue as a symptom or comorbidity of neurological diseases
Nature Reviews Neurology 13 (11): 662-675 (2017-11)



Kotelnikova E.; Kiani N.A.; Abad E.; Martinez-Lapiscina E.H.; Andorra M.; Zubizarreta I.; Pulido-Valdeolivas I.; Pertsovskaya I.; Alexopoulos L.G.; Olsson T.; Martin R.; Paul F.; Tegner J.; Garcia-Ojalvo J.; Villoslada P.
Dynamics and heterogeneity of brain damage in multiple sclerosis
PLoS Computational Biology 13 (10): e1005757 (2017-10-26)



Zimmermann H.G.; Brandt A.U.; Paul F.
Optische Kohaerenztomografie in der Neurologie – Methodik und Anwendung in Forschung und Klinik [optical coherence tomography in neurology: method and application in research and clinical routine]
Klinische Neurophysiologie : (2017-10-18)



Soelberg K.; Jarius S.; Skejoe H.P.B.; Engberg H.; Mehlsen J.J.; Nilsson A.C.; Madsen J.S.; Reindl M.; Wildemann B.; Grauslund J.; Kyvik K.O.; Smith T.J.; Lillevang S.T.; Paul F.; Weinshenker B.G.; Asgari N.
A population-based prospective study of optic neuritis
Multiple Sclerosis Journal : 1352458517734070 (2017-10-05)



Petzold A.; Balcer L.J.; Calabresi P.A.; Costello F.; Frohman T.C.; Frohman E.M.; Martinez-Lapiscina E.H.; Green A.J.; Kardon R.; Outteryck O.; Paul F.; Schippling S.; Vermersch P.; Villoslada P.; Balk L.J.
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Lancet Neurology 16 (10): 797-812 (2017-10)



Dusek P.; Bahn E.; Litwin T.; Jablonka-Salach K.; Luciuk A.; Huelnhagen T.; Madai V.I.; Dieringer M.A.; Bulska E.; Knauth M.; Niendorf T.; Sobesky J.; Paul F.; Schneider S.A.; Czlonkowska A.; Brueck W.; Wegner C.; Wuerfel J.
Brain iron accumulation in Wilson disease: a post-mortem 7 Tesla MRI - histopathological study
Neuropathology and Applied Neurobiology 43 (6): 514-532 (2017-10)



Peer M.; Pruess H.; Ben-Dayan I.; Paul F.; Arzy S.; Finke C.
Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study
Lancet Psychiatry 4 (10): 768-774 (2017-10)



Kessler R.A.; Mealy M.A.; Jimenez-Arango J.A.; Quan C.; Paul F.; Lopez R.; Hopkins S.; Levy M.
Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study
Multiple Sclerosis and Related Disorders 17: 198-201 (2017-10)



Kuchling J.; Brandt A.U.; Paul F.; Scheel M.
Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system
EPMA Journal 8 (3): 279-294 (2017-09)



Yadav S.K.; Motamedi S.; Oberwahrenbrock T.; Oertel F.C.; Polthier K.; Paul F.; Kadas E.M.; Brandt A.U.
CuBe: parametric modeling of 3D foveal shape using cubic Bezier
Biomedical Optics Express 8 (9): 4181-4199 (2017-09-01)



Ziemssen T.; Tumani H.; Sehr T.; Thomas K.; Paul F.; Richter N.; Samara E.; Spiegelstein O.; Sorani E.; Bar-Ilan O.; Mimrod D.; Hayardeny L.
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
Journal of Neuroinflammation 14 (1): 172 (2017-08-31)



Jarius S.; Koenig F.B.; Metz I.; Ruprecht K.; Paul F.; Brueck W.; Wildemann B.
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
Journal of Neuroinflammation 14 (1): 171 (2017-08-29)



Mealy M.A.; Kim S.H.; Schmidt F.; Lopez R.; Jimenez Arango J.A.; Paul F.; Wingerchuk D.M.; Greenberg B.M.; Kim H.Jin.; Levy M.
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Multiple Sclerosis Journal : (2017-08-01)



Stellmann J.P.; Krumbholz M.; Friede T.; Gahlen A.; Borisow N.; Fischer K.; Hellwig K.; Pache F.; Ruprecht K.; Havla J.; Kuempfel T.; Aktas O.; Hartung H.P.; Ringelstein M.; Geis C.; Kleinschnitz C.; Berthele A.; Hemmer B.; Angstwurm K.; Young K.L.; Schuster S.; Stangel M.; Lauda F.; Tumani H.; Mayer C.; Zeltner L.; Ziemann U.; Linker R.A.; Schwab M.; Marziniak M.; Then Bergh F.; Hofstadt-van Oy U.; Neuhaus O.; Zettl U.; Faiss J.; Wildemann B.; Paul F.; Jarius S.; Trebst C.; Kleiter I.
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Journal of Neurology Neurosurgery and Psychiatry 88 (8): 639-647 (2017-08)



Schmidt F.A.; Maas M.B.; Geran R.; Schmidt C.; Kunte H.; Ruprecht K.; Paul F.; Goektas O.; Harms L.
Olfactory dysfunction in patients with primary progressive MS
Neurology Neuroimmunology & Neuroinflammation 4 (4): e369 (2017-07)



Borisow N.; Kleiter I.; Gahlen A.; Fischer K.; Wernecke K.D.; Pache F.; Ruprecht K.; Havla J.; Krumbholz M.; Kuempfel T.; Aktas O.; Ringelstein M.; Geis C.; Kleinschnitz C.; Berthele A.; Hemmer B.; Angstwurm K.; Weissert R.; Stellmann J.P.; Schuster S.; Stangel M.; Lauda F.; Tumani H.; Mayer C.; Zeltner L.; Ziemann U.; Linker R.A.; Schwab M.; Marziniak M.; Then Bergh F.; Hofstadt-van Oy U.; Neuhaus O.; Winkelmann A.; Marouf W.; Rueckriem L.; Faiss J.; Wildemann B.; Paul F.; Jarius S.; Trebst C.; Hellwig K.
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Multiple Sclerosis Journal 23 (8): 1092-1103 (2017-07)



Asgari N.; Flanagan E.P.; Fujihara K.; Kim H.J.; Skejoe H.P.; Wuerfel J.; Kuroda H.; Kim S.H.; Maillart E.; Marignier R.; Pittock S.J.; Paul F.; Weinshenker B.G.
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
Neurology Neuroimmunology & Neuroinflammation 4 (4): e343 (2017-07)



Papazoglou S.; Wuerfel J.; Paul F.; Brandt A.U.; Scheel M.
Single-subject independent component analysis-based intensity normalization in non-quantitative multi-modal structural MRI
Human Brain Mapping 38 (7): 3615-3622 (2017-07)



Albrecht P.; Blasberg C.; Ringelstein M.; Mueller A.K.; Finis D.; Guthoff R.; Kadas E.M.; Lagreze W.; Aktas O.; Hartung H.P.; Paul F.; Brandt A.U.; Methner A.
Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension
Journal of Neurology 264 (7): 1370-1380 (2017-07)



Weygandt M.; Wakonig K.; Behrens J.; Meyer-Arndt L.; Soeder E.; Brandt A.U.; Bellmann-Strobl J.; Ruprecht K.; Gold S.M.; Haynes J.-D.; Paul F.
Brain activity, regional gray matter loss, and decision-making in multiple sclerosis
Multiple Sclerosis Journal : (2017-06-28)



Hahn S.; Trendelenburg G.; Scharf M.; Denno Y.; Brakopp S.; Teegen B.; Probst C.; Wandinger K.P.; Buttmann M.; Haarmann A.; Szabados F.; Vom Dahl M.; Kuempfel T.; Eichhorn P.; Gold H.; Paul F.; Jarius S.; Melzer N.; Stoecker W.; Komorowski L.
Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis
Journal of Neuroinflammation 14 (1): 123 (2017-06-23)



Schlemm L.; Chien C.; Bellmann-Strobl J.; Doerr J.; Wuerfel J.; Brandt A.U.; Paul F.; Scheel M.
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients
Multiple Sclerosis Journal 23 (7): 963-972 (2017-06)



Streitberger K.J.; Fehlner A.; Pache F.; Lacheta A.; Papazoglou S.; Bellmann-Strobl J.; Ruprecht K.; Brandt A.; Braun J.; Sack I.; Paul F.; Wuerfel J.
Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder
European Radiology 27 (5): 2206-2215 (2017-05)



Bove R.; Elsone L.; Alvarez E.; Borisow N.; Cortez M.M.; Mateen F.J.; Mealy M.A.; Mutch K.; Tobyne S.; Ruprecht K.; Buckle G.; Levy M.; Wingerchuk D.M.; Paul F.; Cross A.H.; Weinshenker B.; Jacob A.; Klawiter E.C.; Chitnis T.
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
Neurology Neuroimmunology & Neuroinflammation 4 (3): e339 (2017-05)



Oertel F.C.; Kuchling J.; Zimmermann H.; Chien C.; Schmidt F.; Knier B.; Bellmann-Strobl J.; Korn T.; Scheel M.; Klistorner A.; Ruprecht K.; Paul F.; Brandt A.U.
Microstructural visual system changes in AQP4-antibody-seropositive NMOSD
Neurology Neuroimmunology & Neuroinflammation 4 (3): e334 (2017-05)



Oertel F.C.; Zimmermann H.; Mikolajczak J.; Weinhold M.; Kadas E.M.; Oberwahrenbrock T.; Pache F.; Bellmann-Strobl J.; Ruprecht K.; Paul F.; Brandt A.U.
Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD
Neurology Neuroimmunology & Neuroinflammation 4 (3): e338 (2017-05)



Berndt D.; Millward J.M.; Schnorr J.; Taupitz M.; Stangl V.; Paul F.; Wagner S.; Wuerfel J.T.; Sack I.; Ludwig A.; Infante-Duarte C.
Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans
Nanomedicine: Nanotechnology, Biology and Medicine 13 (4): 1411-1421 (2017-05)



Lang V.; Zille M.; Infante-Duarte C.; Jarius S.; Jahn H.; Paul F.; Ruprecht K.; Pina A.L.
Alzheimer's disease: elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin
Journal of the Neurological Sciences 375: 123-128 (2017-04-15)



Giess R.M.; Pfuhl C.; Behrens J.R.; Rasche L.; Freitag E.; Khalighy N.; Otto C.; Wuerfel J.; Brandt A.U.; Hofmann J.; Eberspaecher B.; Bellmann-Strobl J.; Paul F.; Ruprecht K.
Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
PLoS ONE 12 (4): e0175279 (2017-04-07)



Dianzani C.; Bellavista E.; Liepe J.; Verderio Cl.; Martucci M.; Santoro A.; Chiocchetti A.; Luca Gigliotti C.; Boggio E.; Ferrara B.; Riganti L.; Keller C.; Janek K.; Niewienda A.; Fenoglio C.; Sorosina M.; Cantello R.; Kloetzel P.M.; Stumpf M.P.H.; Paul F.; Ruprecht K.; Galimberti D.; Martinelli Boneschi F.; Comi C.; Dianzani U.; Mishto M.
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis
Scientific Reports 7: 43718 (2017-03-09)



Schlemm L.; Radbruch H.; Brandt A.U.; Scheel M.; Paul F.
Histopathologic assessment of neurotoxicity after repeated administration of gadodiamide in healthy rats
Radiology 282 (3): 925-926 (2017-03)



Pache F.; Wildemann B.; Paul F.; Jarius S.
Neuromyelitis optica
Fortschritte der Neurologie Psychiatrie 85 (2): 100-114 (2017-02)



Siegert E.; Paul F.; Rothe M.; Weylandt Karsten H
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
BMC Neuroscience 18 (1): 19 (2017-01-24)



Krueger T.; Behrens J.R.; Grobelny A.; Otte K.; Mansow-Model S.; Kayser B.; Bellmann-Strobl J.; Brandt A.U.; Paul F.; Schmitz-Huebsch T.
Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life
BMC Neurology 17 (1): 10 (2017-01-13)



Schmidt F.; Zimmermann H.; Mikolajczak J.; Oertel F.C.; Pache F.; Weinhold M.; Schinzel J.; Bellmann-Strobl J.; Ruprecht K.; Paul F.; Brandt A.U.
Severe structural and functional visual system damage leads to profound loss of Vision-related quality of life in patients with neuromyelitis optica spectrum disorders
Multiple sclerosis and related disorders 11: 45-50 (2017-01)



Paul F.
Kognitive Stoerungen bei Multipler Sklerose und anderen autoimmunen Erkrankungen des zentralen Nervensystems [Cognitive dysfunction in multiple sclerosis and other autoimmune disorders in central nervous system]
Journal fuer Neurologie Neurochirurgie und Psychiatrie 18 (1): 4-10 (2017)



Finke C.; Pruess H.; Heine J.; Reuter S.; Kopp U.A.; Wegner F.; Then Bergh F.; Koch S.; Jansen O.; Muente T.; Deuschl G.; Ruprecht K.; Stoecker W.; Wandinger K.P.; Paul F.; Bartsch T.
Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies
JAMA Neurology 74 (1): 50-59 (2017-01)



2016

Kleffner Ilka; Doerr Jan; Ringelstein Marius; Gross Catharina C; Boeckenfeld Yvonne; Schwindt Wolfram; Sundermann Benedikt; Lohmann Hubertus; Wersching Heike; Promesberger Julia; von Koenigsmarck Natascha; Alex Anne; Guthoff Rainer; Frijns Catharina J M; Kappelle L Jaap; Jarius Sven; Wildemann Brigitte; Aktas Orhan; Paul F.; Wiendl Heinz; Duning Thomas
Diagnostic criteria for Susac syndrome
Journal of Neurology Neurosurgery and Psychiatry 87 (12): 1287-1295 (2016-12-25)



Bremer D.; Pache F.; Guenther R.; Hornow J.; Andresen V.; Leben R.; Mothes R.; Zimmermann H.; Brandt A.U.; Paul F.; Hauser A.E.; Radbruch H.; Niesner R.
Longitudinal intravital imaging of the retina reveals long-term dynamics of immune infiltration and its effects on the glial network in experimental autoimmune uveoretinitis, without evident signs of neuronal dysfunction in the ganglion cell layer
Frontiers in Immunology 7: 642 (2016-12-23)



Huss A.M.; Halbgebauer S.; Oeckl P.; Trebst C.; Spreer A.; Borisow N.; Harrer A.; Brecht I.; Balint B.; Stich O.; Schlegel S.; Retzlaff N.; Winkelmann A.; Roesler R.; Lauda F.; Yildiz O.; Voss E.; Muche R.; Rauer S.; Bergh F.T.; Otto M.; Paul F.; Wildemann B.; Kraus J.; Ruprecht K.; Stangel M.; Buttmann M.; Zettl U.K.; Tumani H.
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome
Journal of Neurology 263 (12): 2499-2504 (2016-12)



Chavarro V.S.; Mealy M.A.; Simpson A.; Lacheta A.; Pache F.; Ruprecht K.; Gold S.M.; Paul F.; Brandt A.U.; Levy M.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
Neurology Neuroimmunology & Neuroinflammation 3 (6): e286 (2016-12)



Pache F.; Zimmermann H.; Finke C.; Lacheta A.; Papazoglou S.; Kuchling J.; Wuerfel J.; Hamm B.; Ruprecht K.; Paul F.; Brandt A.U.; Scheel M.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - a multimodal MRI study
European Radiology 26 (12): 4413-4422 (2016-12)



Veauthier C.; Paul F.
Therapie der Fatigue bei Multipler Sklerose: Ein Behandlungsalgorithmus [Therapy of fatigue in multiple sclerosis : a treatment algorithm]
Nervenarzt 87 (12): 1310-1321 (2016-12)



Veauthier C.; Hasselmann H.; Gold S.M.; Paul F.
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
EPMA Journal 7: 25 (2016-11-24)



Weygandt M.; Meyer-Arndt L.; Behrens J.R.; Wakonig K.; Bellmann-Strobl J.; Ritter K.; Scheel M.; Brandt A.U.; Labadie C.; Hetzer S.; Gold S.M.; Paul F.; Haynes J.D.
Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis
Proceedings of the National Academy of Sciences of the United States of America 113 (47): 13444-13449 (2016-11-22)



Sinnecker T.; Othman J.; Kuehl M.; Metz I.; Niendorf T.; Kunkel A.; Paul F.; Wuerfel J.; Faiss Juergen
Progressive multifocal leukoencephalopathy in a multiple Sclerosis patient diagnosed after switching from natalizumab to fingolimod
Case Reports in Neurological Medicine 2016: 5876798 (2016-11-22)



Otte K.; Kayser B.; Mansow-Model S.; Verrel J.; Paul F.; Brandt A.U.; Schmitz-Huebsch T.
Accuracy and reliability of the kinect version 2 for clinical measurement of motor function
PLoS ONE 11 (11): e0166532 (2016-11-18)



Huhn K.; Laemmer R.; Zimmermann H.; Laemmer A.; Waschbisch A.; Utz K.; Giess R.M.; Paul F.; Linker R.A.; Lee D.H.
Retinal imaging and axonal degeneration in later onset multiple sclerosis
Journal of the Neurological Sciences 370: 1-6 (2016-11-15)



Mikolajczak J.; Zimmermann H.; Kheirkhah A.; Kadas E.M.; Oberwahrenbrock T.; Muller R.; Ren A.; Kuchling J.; Dietze H.; Pruess H.; Paul F.; Hamrah P.; Brandt A.U.
Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density
Multiple Sclerosis Journal : (2016-11-03)



Jarius S.; Kleiter I.; Ruprecht K.; Asgari N.; Pitarokoili K.; Borisow N.; Huemmert M.W.; Trebst C.; Pache F.; Winkelmann A.; Beume L.A.; Ringelstein M.; Stich O.; Aktas O.; Korporal-Kuhnke M.; Schwarz A.; Lukas C.; Haas J.; Fechner K.; Buttmann M.; Bellmann-Strobl J.; Zimmermann H.; Brandt A.U.; Franciotta D.; Schanda K.; Paul F.; Reindl M.; Wildemann B.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
Journal of Neuroinflammation 13 (1): 281 (2016-11-01)



Pache F.; Zimmermann H.; Mikolajczak J.; Schumacher S.; Lacheta A.; Oertel F.C.; Bellmann-Strobl J.; Jarius S.; Wildemann B.; Reindl M.; Waldman A.; Soelberg K.; Asgari N.; Ringelstein M.; Aktas O.; Gross N.; Buttmann Ma.; Ach T.; Ruprecht K.; Paul F.; Brandt A.U.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
Journal of Neuroinflammation 13 (1): 282 (2016-11-01)



Jarius S.; Ruprecht K.; Kleiter I.; Borisow N.; Asgari N.; Pitarokoili K.; Pache F.; Stich O.; Beume L.A.; Huemmert M.W.; Ringelstein M.; Trebst C.; Winkelmann A.; Schwarz A.; Buttmann M.; Zimmermann H.; Kuchling J.; Franciotta D.; Capobianco M.; Siebert E.; Lukas C.; Korporal-Kuhnke M.; Haas J.; Fechner K.; Brandt A.U.; Schanda K.; Aktas O.; Paul F.; Reindl M.; Wildemann B.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Journal of Neuroinflammation 13 (1): 280 (2016-10-28)



Brandt A.U.; Meinert-Bohn E.; Rinnenthal J.; Zimmermann H.; Mikolajczak J.; Oberwahrenbrock T.; Papazoglou S.; Pfueller C.F.; Schinzel J.; Tackenberg B.; Paul F.; Hahn K.; Bellmann-Strobl J.
Afferent visual pathway affection in patients with PMP22 deletion-related hereditary neuropathy with liability to pressure palsies.
PLoS ONE 11 (10): e0164617 (2016-10-17)



Paul F.
What is the future of proof of concept studies in multiple sclerosis?
Lancet Neurology 15 (11): 1107-1109 (2016-10)



Jarius S.; Metz I.; Koenig F.B.; Ruprecht K.; Reindl M.; Paul F.; Brueck W.; Wildemann B.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Multiple Sclerosis Journal 22 (12): 1541-1549 (2016-10)



Kreye J.; Wenke N.K.; Chayka M.; Leubner J.; Murugan R.; Maier N.; Jurek B.; Ly L.T.; Brandl D.; Rost B.R.; Stumpf A.; Schulz P.; Radbruch H.; Hauser A.E.; Pache F.; Meisel A.; Harms L.; Paul F.; Dirnagl U.; Garner C.; Schmitz D.; Wardemann H.; Pruess H.
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis
Brain 139 (10): 2641-2652 (2016-10-01)



Behrens J.R.; Mertens S.; Krueger T.; Grobelny A.; Otte K.; Mansow-Model S.; Gusho E.; Paul F.; Brandt A.U.; Schmitz-Huebsch T.
Validity of visual perceptive computing for static posturography in patients with multiple sclerosis
Multiple Sclerosis Journal 22 (12): 1596-1606 (2016-10)



Hasselmann H.; Bellmann-Strobl J.; Ricken R.; Oberwahrenbrock T.; Rose M.; Otte C.; Adli M.; Paul F.; Brandt A.U.; Finke C.; Gold S.M.
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression
Multiple Sclerosis Journal 22 (11): 1476-1484 (2016-10)



Jarius S.; Ruprecht K.; Kleiter I.; Borisow N.; Asgari N.; Pitarokoili K.; Pache F.; Stich O.; Beume L.A.; Huemmert M.W.; Trebst C.; Ringelstein M.; Aktas O.; Winkelmann A.; Buttmann M.; Schwarz A.; Zimmermann H.; Brandt A.U.; Franciotta D.; Capobianco M.; Kuchling J.; Haas J.; Korporal-Kuhnke M.; Lillevang S.T.; Fechner K.; Schanda K.; Paul F.; Wildemann B.; Reindl M.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Journal of Neuroinflammation 13 (1): 279 (2016-09-26)



Paul F.
Pathology and MRI: exploring cognitive impairment in MS
Acta Neurologica Scandinavica 134 (Suppl 200): 24-33 (2016-09)



Waters P.; Reindl M.; Saiz A.; Schanda K.; Tuller F.; Kral V.; Nytrova P.; Sobek O.; Nielsen H.H.; Barington T.; Lillevang S.T.; Illes Z.; Rentzsch K.; Berthele A.; Berki T.; Granieri L.; Bertolotto A.; Giometto B.; Zuliani L.; Hamann D.; van Pelt E.D.; Hintzen R.; Hoeftberger R.; Costa C.; Comabella M.; Montalban X.; Tintore M.; Siva A.; Altintas A.; Deniz G.; Woodhall M.; Palace J.; Paul F.; Hartung H.P.; Aktas O.; Jarius S.; Wildemann B.; Vedeler C.; Ruiz A.; Leite M.I.; Trillenberg P.; Probst M.; Saschenbrecker S.; Vincent A.; Marignier R.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Journal of Neurology Neurosurgery and Psychiatry 87 (9): 1005-1015 (2016-09)



Schlemm L.; Giess R.M.; Rasche L.; Pfuhl C.; Wakonig K.; Behrens J.R.; Scheibenbogen C.; Bellmann-Strobl J.; Paul F.; Reimer U.; Ruprecht K.
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: a peptide microarray-based case-control study
Journal of Neuroimmunology 297: 56-62 (2016-08-15)



Soelberg K.; Larsen S.R.; Moerch M.T.; Thomassen M.; Brusgaard K.; Paul F.; Smith T.J.; Godballe C.; Grauslund J.; Lillevang S.T.; Asgari N.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer
Neurology Neuroimmunology & Neuroinflammation 3 (4): e252 (2016-08)



Sinnecker T.; Schumacher S.; Mueller K.; Pache F.; Dusek P.; Harms L.; Ruprecht K.; Nytrova P.; Chawla S.; Niendorf T.; Kister I.; Paul F.; Ge Y.; Wuerfel J.
MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T
Neurology Neuroimmunology & Neuroinflammation 3 (4): e259 (2016-08)



Keshavan A.; Paul F.; Beyer M.K.; Zhu A.H.; Papinutto N.; Shinohara R.T.; Stern W.; Amann M.; Bakshi R.; Bischof A.; Carriero A.; Comabella M.; Crane J.C.; D'Alfonso S.; Demaerel P.; Dubois B.; Filippi M.; Fleischer V.; Fontaine B.; Gaetano L.; Goris A.; Graetz C.; Groeger A.; Groppa S.; Hafler D.A.; Harbo H.F.; Hemmer B.; Jordan K.; Kappos L.; Kirkish G.; Llufriu S.; Magon S.; Martinelli-Boneschi F.; McCauley J.; Montalban X.; Muhlau M.; Pelletier D.; Pattany P.M.; Pericak-Vance M.; Rebeix I.; Rocca M.; Rovira A.; Schlaeger R.; Saiz A.; Sprenger T.; Stecco A.; Uitdehaag B.M.J.; Villoslada P.; Wattjes M.P.; Weiner H.; Wuerfel J.; Zimmer C.; Zipp F.; Hauser S.; Oksenberg J.R.; Henry R.G.
Power estimation for non-standardized multisite studies
NeuroImage 134: 281-294 (2016-07-01)



Fehlner A.; Behrens J.R.; Streitberger K.J.; Papazoglou S.; Braun J.; Bellmann-Strobl J.; Ruprecht K.; Paul F.; Wuerfel J.; Sack I.
Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome
Journal of Magnetic Resonance Imaging 44 (1): 51-58 (2016-07)



Schmitz-Huebsch T.; Brandt A.U.; Pfueller C.; Zange L.; Seidel A.; Kuehn A.A.; Paul F.; Minnerop M.; Doss S.
Accuracy and repeatability of two methods of gait analysis - GaitRite(TM) und Mobility Lab(TM) - in subjects with cerebellar ataxia
Gait & Posture 48: 194-201 (2016-07)



Chawla S.; Kister I.; Wuerfel J.; Brisset J.C.; Liu S.; Sinnecker T.; Dusek P.; Haacke E.M.; Paul F.; Ge Y.
Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI
American Journal of Neuroradiology 37 (7): 1223-1230 (2016-07)



Andlauer T.F.M.; Buck D.; Antony G.; Bayas A.; Bechmann L.; Berthele A.; Chan A.; Gasperi C.; Gold R.; Graetz C.; Haas J.; Hecker M.; Infante-Duarte C.; Knop M.; Kuempfel T.; Limmroth V.; Linker R.A.; Loleit V.; Luessi F.; Meuth S.G.; Muehlau M.; Nischwitz S.; Paul F.; Puetz M.; Ruck T.; Salmen A.; Stangel M.; Stellmann J.P.; Stuerner K.H.; Tackenberg B.; Then Bergh F.; Tumani H.; Warnke C.; Weber F.; Wiendl H.; Wildemann B.; Zettl U.K.; Ziemann U.; Zipp F.; Arloth J.; Weber P.; Radivojkov-Blagojevic M.; Scheinhardt M.O.; Dankowski T.; Bettecken T.; Lichtner P.; Czamara D.; Carrillo-Roa T.; Binder E.B.; Berger K.; Bertram L.; Franke A.; Gieger C.; Herms S.; Homuth G.; Ising M.; Joeckel K.H.; Kacprowski T.; Kloiber S.; Laudes M.; Lieb W.; Lill C.M.; Lucae S.; Meitinger T.; Moebus S.; Mueller-Nurasyid M.; Noethen M.M.; Petersmann A.; Rawal R.; Schminke U.; Strauch K.; Voelzke H.; Waldenberger M.; Wellmann J.; Porcu E.; Mulas A.; Pitzalis M.; Sidore C.; Zara I.; Cucca F.; Zoledziewska M.; Ziegler A.; Hemmer B.; Mueller-Myhsok B.
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation
Science Advances 2 (6): e1501678 (2016-06-17)



Cruz-Herranz A.; Balk L.J.; Oberwahrenbrock T.; Saidha S.; Martinez-Lapiscina E.H.; Lagreze W.A.; Schuman J.S.; Villoslada P.; Calabresi P.; Balcer L.; Petzold A.; Green A.J.; Paul F.; Brandt A.U.; Albrecht P.
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
Neurology 86 (24): 2303-2309 (2016-06-14)



Choi I.Y.; Piccio L.; Childress P.; Bollman B.; Ghosh A.; Brandhorst S.; Suarez J.; Michalsen A.; Cross A.H.; Morgan T.E.; Wei M.; Paul F.; Bock M.; Longo V.D.
A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms
Cell Reports 15 (10): 2136-2146 (2016-06-07)



Schumacher S.; Pache F.; Bellmann-Strobl J.; Behrens J.; Dusek P.; Harms L.; Ruprecht K.; Nytrova P.; Chawla S.; Niendorf T.; Kister I.; Paul F.; Ge Y.; Wuerfel J.; Sinnecker T.
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study
Magnetic Resonance Materials in Physics, Biology and Medicine 29 (3): 535-541 (2016-06)



Klotz L.; Berthele A.; Brueck W.; Chan A.; Flachenecker P.; Gold R.; Haghikia A.; Hellwig K.; Hemmer B.; Hohlfeld R.; Korn T.; Kuempfel T.; Lang M.; Limmroth V.; Linker R.A.; Meier U.; Meuth S.G.; Paul F.; Salmen A.; Stangel M.; Tackenberg B.; Tumani H.; Warnke C.; Weber M.S.; Ziemssen T.; Zipp F.; Wiendl H.
Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie : Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen [Monitoring of blood parameters under course-modified MS therapy : substance-specific relevance and current recommendations for action]
Nervenarzt 87 (6): 645-659 (2016-06)



Finke C.; Heine J.; Pache F.; Lacheta A.; Borisow N.; Kuchling J.; Bellmann-Strobl J.; Ruprecht K.; Brandt A.U.; Paul F.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD
Neurology Neuroimmunology & Neuroinflammation 3 (3): e229 (2016-06)



Cree B.A.C.; Bennett J.L.; Sheehan M.; Cohen J.; Hartung H.P.; Aktas O.; Kim H.J.; Paul F.; Pittock S.; Weinshenker B.; Wingerchuk D.; Fujihara K.; Cutter G.; Patra K.; Flor A.; Barron G.; Madani S.; Ratchford J.N.; Katz E.
Placebo-controlled study in neuromyelitis optica : ethical and design considerations
Multiple Sclerosis Journal 22 (7): 862-872 (2016-06)



Blaabjerg M.; Ruprecht K.; Sinnecker T.; Kondziella D.; Niendorf T.; Kerrn-Jespersen B.M.; Lindelof M.; Lassmann H.; Kristensen B.W.; Paul F.; Illes Z.
Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI
Neurology Neuroimmunology & Neuroinflammation 3 (3): e226 (2016-06)



Martinez-Lapiscina E.H.; Arnow S.; Wilson J.A.; Saidha S.; Preiningerova J.L.; Oberwahrenbrock T.; Brandt A.U.; Pablo L.E.; Guerrieri S.; Gonzalez I.; Outteryck O.; Mueller A.K.; Albrecht P.; Chan W.; Lukas S.; Balk L.J.; Fraser C.; Frederiksen J.L.; Resto J.; Frohman T.; Cordano C.; Zubizarreta I.; Andorra M.; Sanchez-Dalmau B.; Saiz A.; Bermel R.; Klistorner A.; Petzold A.; Schippling S.; Costello F.; Aktas O.; Vermersch P.; Oreja-Guevara C.; Comi G.; Leocani L.; Garcia-Martin E.; Paul F.; Havrdova E.; Frohman E.; Balcer L.J.; Green A.J.; Calabresi P.A.; Villoslada P.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Lancet Neurology 15 (6): 574-584 (2016-05)



Finke C.; Kopp U.A.; Pajkert A.; Behrens J.R.; Leypoldt F.; Wuerfel J.T.; Ploner C.J.; Pruess H.; Paul F.
Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis
Biological Psychiatry 79 (9): 727-734 (2016-05-01)



Brandt A.U.; Oberwahrenbrock T.; Mikolajczak J.; Zimmermann H.; Pruess H.; Paul F.; Finke C.
Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis
Neurology Neuroimmunology & Neuroinflammation 3 (2): e198 (2016-04)



Metz I.; Beißbarth T.; Ellenberger D.; Pache F.; Stork L.; Ringelstein M.; Aktas O.; Jarius S.; Wildemann B.; Dihazi H.; Friede T.; Brueck W.; Ruprecht K.; Paul F.
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Neurology Neuroimmunology & Neuroinflammation 3 (2): e204 (2016-04)



Levin J.; Maass S.; Schuberth M.; Respondek G.; Paul F.; Mansmann U.; Oertel W.H.; Lorenzl S.; Krismer F.; Seppi K.; Poewe W.; Wenning G.; Giese A.; Boetzel K.; Hoeglinger G.
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach
Journal of Neural Transmission 123 (4): 439-445 (2016-04)



Ayzenberg I.; Schoellhammer J.; Hoepner R.; Hellwig K.; Ringelstein M.; Aktas O.; Kuempfel T.; Krumbholz M.; Trebst C.; Paul F.; Pache F.; Obermann M.; Zeltner L.; Schwab M.; Berthele A.; Jarius S.; Kleiter I.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
Journal of Neurology 263 (3): 575-582 (2016-03)



Kuchenbecker J.; Blum M.; Paul F.
Untersuchung des Farbsehens bei akuter einseitiger Neuritis nervi optici mittels eines webbasierten Farbsehtests [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test]
Ophthalmologe 113 (3): 223-229 (2016-03)



Rommer P.S.; Doerner T.; Freivogel K.; Haas J.; Kieseier B.C.; Kuempfel T.; Paul F.; Proft F.; Schulze-Koops H.; Schmidt E.; Wiendl H.; Ziemann U.; Zettl U.K.
Safety and clinical outcomes of rituximab treatment in patients with multiple sclerosis and neuromyelitis optica: experience from a national online registry (GRAID)
Journal of Neuroimmune Pharmacology 11 (1): 1-8 (2016-03)



Miyaji K.; Paul F.; Shahrizaila N.; Umapathi T.; Yuki N.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases
Journal of Neuroimmunology 291: 78-81 (2016-02-15)



Brandt A.U.; Oberwahrenbrock T.; Costello F.; Fielden M.; Gertz K.; Kleffner I.; Paul F.; Bergholz R.; Doerr J.
Retinal lesion evolution in susac syndrome
Retina 36 (2): 366-374 (2016-02)



Kleiter I.; Gahlen A.; Borisow N.; Fischer K.; Wernecke K.D.; Wegner B.; Hellwig K.; Pache F.; Ruprecht K.; Havla J.; Krumbholz M.; Kuempfel T.; Aktas O.; Hartung H.P.; Ringelstein M.; Geis C.; Kleinschnitz C.; Berthele A.; Hemmer B.; Angstwurm K.; Stellmann J.P.; Schuster S.; Stangel M.; Lauda F.; Tumani H.; Mayer C.; Zeltner L.; Ziemann U.; Linker R.; Schwab M.; Marziniak M.; Bergh F.T.; Hofstadt-van Oy U.; Neuhaus O.; Winkelmann A.; Marouf W.; Faiss J.; Wildemann B.; Paul F.; Jarius S.; Trebst C.
Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses
Annals of Neurology 79 (2): 206-216 (2016-02)



Volz M.S.; Finke C.; Harms L.; Jurek B.; Paul F.; Floeel A.; Pruess H.
Altered paired associative stimulation-induced plasticity in NMDAR encephalitis
Annals of Clinical and Translational Neurology 3 (2): 101-113 (2016-02)



Hertwig L.; Pache F.; Romero-Suarez S.; Stuerner K.H.; Borisow N.; Behrens J.; Bellmann-Strobl J.; Seeger B.; Asselborn N.; Ruprecht K.; Millward J.M.; Infante-Duarte C.; Paul F.
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica
Multiple Sclerosis Journal 22 (2): 160-173 (2016-02)



Rasche L.; Heiserich L.; Behrens J.R.; Lenz K.; Pfuhl C.; Wakonig K.; Gieß R.M.; Freitag E.; Eberle C.; Wuerfel J.; Doerr J.; Bauer P.; Bellmann-Strobl J.; Paul F.; Roggenbuck D.; Ruprecht K.
Analysis of lymphocytic DNA damage in early multiple sclerosis by automated {gamma}-H2AX and 53BP1 foci detection: A case control study
PLoS ONE 11 (1): e0147968 (2016-01-28)



Behrens J.R.; Rasche L.; Giess R.M.; Pfuhl C.; Wakonig K.; Freitag E.; Deuschle K.; Bellmann-Strobl J.; Paul F.; Ruprecht K.; Doerr J.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis
European Journal of Neurology 23 (1): 62-67 (2016-01)



Jurynczyk M.; Weinshenker B.; Akman-Demir G.; Asgari N.; Barnes D.; Boggild M.; Chaudhuri A.; D'hooghe M.; Evangelou N.; Geraldes R.; Illes Z.; Jacob A.; Kim H.J.; Kleiter I.; Levy M.; Marignier R.; McGuigan C.; Murray K.; Nakashima I.; Pandit L.; Paul F.; Pittock S.; Selmaj K.; de Seze J.; Siva A.; Tanasescu R.; Vukusic S.; Wingerchuk D.; Wren D.; Leite I.; Palace J.
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
Journal of Neurology 263 (1): 140-149 (2016-01)



Veauthier C.; Gaede G.; Radbruch H.; Wernecke K.D.; Paul F.
Poor sleep in multiple sclerosis correlates with Beck Depression Inventory values, but not with polysomnographic data
Sleep Disorders 2016: 8378423 (2016)



2015

Hoffmann S.; Siedler J.; Brandt A.U.; Piper S.K.; Kohler S.; Sass C.; Paul F.; Reilmann R.; Meisel A.
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study
BMC Neurology 15 (1): 265 (2015-12-23)



Sinnecker T.; Othman J.; Kuehl M.; Mekle R.; Selbig I.; Niendorf T.; Kunkel A.; Wienecke P.; Kern P.; Paul F.; Faiss J.; Wuerfel J.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: a case study
Neurology Neuroimmunology & Neuroinflammation 2 (6): e171 (2015-12)



Dankowski T.; Buck D.; Andlauer T.F.M.; Antony G.; Bayas A.; Bechmann L.; Berthele A.; Bettecken T.; Chan A.; Franke A.; Gold R.; Graetz C.; Haas J.; Hecker M.; Herms S.; Infante-Duarte C.; Joeckel K.H.; Kieseier B.C.; Knier B.; Knop M.; Kuempfel T.; Lichtner P.; Lieb W.; Lill C.M.; Limmroth V.; Linker R.A.; Loleit V.; Meuth S.G.; Moebus S.; Mueller-Myhsok B.; Nischwitz S.; Noethen M.M.; Paul F.; Puetz M.; Ruck T.; Salmen A.; Stangel M.; Stellmann J.P.; Strauch K.; Stuerner K.H.; Tackenberg B.; Then Bergh F.; Tumani H.; Waldenberger M.; Weber F.; Wiendl H.; Wildemann B.; Zettl U.K.; Ziemann U.; Zipp F.; Hemmer B.; Ziegler A.
Successful replication of GWAS hits for multiple sclerosis in 10,000 Germans using the exome array
Genetic Epidemiology 39 (8): 601-608 (2015-12)



Mossakowski A.A.; Pohlan J.; Bremer D.; Lindquist R.; Millward J.M.; Bock M.; Pollok K.; Mothes R.; Viohl L.; Radbruch M.; Gerhard J.; Bellmann-Strobl J.; Behrens J.; Infante-Duarte C.; Maehler A.; Boschmann M.; Rinnenthal J.L.; Fuechtemeier M.; Herz J.; Pache F.C.; Bardua M.; Priller J.; Hauser A.E.; Paul F.; Niesner R.; Radbruch H.
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation
Acta Neuropathologica 130 (6): 799-814 (2015-12)



Heine J.; Pruess H.; Bartsch T.; Ploner C.J.; Paul F.; Finke C.
Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function
Neuroscience 309: 68-83 (2015-11-19)



Keller A.; Leidinger P.; Meese E.; Haas J.; Backes C.; Rasche L.; Behrens J.R.; Pfuhl C.; Wakonig K.; Giess R.M.; Jarius S.; Meder B.; Bellmann-Strobl J.; Paul F.; Pache F.C.; Ruprecht K.
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis
Journal of Neuroinflammation 12 (1): 196 (2015-10-31)



Kunte H.; Paul F.; Pache F.; Doerr J.; Bellmann-Strobl J.; Harms L.; Kronenberg G.
Iridodonesis as a cause of recurrent vertigo
Neurology 85 (15): 1353 (2015-10-13)



Pohland M.; Glumm R.; Stoenica L.; Hoeltje M.; Kiwit J.; Ahnert-Hilger G.; Strauss U.; Braeuer A.U.; Paul F.; Glumm J.
Studying axonal outgrowth and regeneration of the corticospinal tract in organotypic slice cultures
Journal of Neurotrauma 32 (19): 1465-1477 (2015-10-01)



Villoslada P.; Rovira A.; Montalban X.; Arroyo R.; Paul F.; Meca-Lallana V.; Ramo C.; Fernandez O.; Saiz A.; Garcia-Merino A.; Ramio-Torrenta L.; Casanova B.; Oreja-Guevara C.; Munoz D.; Martinez-Rodriguez J.E.; Lensch E.; Prieto J.M.; Meuth S.G.; Nunez X.; Campas C.; Pugliese M.
Effects of diazoxide in multiple sclerosis: a randomized, double-blind phase 2 clinical trial
Neurology Neuroimmunology & Neuroinflammation 2 (5): e147 (2015-10)



Hartmann C.J.; Klistorner A.I.; Brandt A.U.; Schroeder K.; Kolbe R.; Cohn E.; Goebels N.; Guthoff R.; Aktas O.; Hartung H.P.; Albrecht P.
Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials
Clinical Neurophysiology 126 (10): 2040-2041 (2015-10)



Ewering C.; Hasal N.; Alten F.; Clemens C.R.; Eter N.; Oberwahrenbrock T.; Kadas E.M.; Zimmermann H.; Brandt A.U.; Osada N.; Paul F.; Marziniak M.
Temporal retinal nerve fibre layer thinning in cluster headache patients detected by optical coherence tomography
Cephalalgia 35 (11): 946-958 (2015-10)



Veauthier C.; Gaede G.; Radbruch H.; Sieb J.P.; Wernecke K.D.; Paul F.
Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
Neuropsychiatric Disease and Treatment 11: 2323-2329 (2015-09-09)



Oberwahrenbrock T.; Weinhold M.; Mikolajczak J.; Zimmermann H.; Paul F.; Beckers I.; Brandt A.U.
Reliability of intra-retinal layer thickness estimates
PLoS ONE 10 (9): e0137316 (2015-09-08)



Kheirkhah A.; Muller R.; Mikolajczak J.; Ren A.; Kadas E.M.; Zimmermann H.; Pruess H.; Paul F.; Brandt A.U.; Hamrah P.
Comparison of standard versus wide-field composite images of the corneal subbasal layer by In vivo confocal microscopy
Investigative Ophthalmology & Visual Science 56 (10): 5801-5807 (2015-09-01)



Sinnecker T.; Kuchling J.; Dusek P.; Doerr J.; Niendorf T.; Paul F.; Wuerfel J.T.
The contribution of ultrahigh field MRI to imaging research in clinical neuroimmunology
EPMA Journal 6 (1): 16 (2015-08-27)



Sinnecker T.; Kuchling J.; Dusek P.; Doerr J.; Niendorf T.; Paul F.; Wuerfel J.
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management
EPMA Journal 6 (1): 16 (2015-08-27)



Ringelstein M.; Albrecht P.; Kleffner I.; Buehn B.; Harmel J.; Mueller A.K.; Finis D.; Guthoff R.; Bergholz R.; Duning T.; Kraemer M.; Paul F.; Brandt A.; Oberwahrenbrock T.; Mikolajczak J.; Wildemann B.; Jarius S.; Hartung H.P.; Aktas O.; Doerr J.
Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography
Neurology 85 (7): 610-618 (2015-08-18)



Stascheit F.; Paul F.; Harms L.; Rosche B.
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis
Journal of Neuroimmunology 285: 119-124 (2015-08-15)



Pfuhl C.; Oechtering J.; Rasche L.; Giess R.M.; Behrens J.R.; Wakonig K.; Freitag E.; Pache F.C.; Otto C.; Hofmann J.; Eberspaecher B.; Bellmann-Strobl J.; Paul F.; Ruprecht K.
Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis
Journal of Neuroimmunology 285: 156-160 (2015-08-15)



Albrecht P.; Blasberg C.; Lukas S.; Ringelstein M.; Mueller A.K.; Harmel J.; Kadas E.M.; Finis D.; Guthoff R.; Aktas O.; Hartung H.P.; Paul F.; Brandt A.U.; Berlit P.; Methner A.; Kraemer M.
Retinal pathology in idiopathic moyamoya angiopathy detected by optical coherence tomography
Neurology 85 (6): 521-527 (2015-08-11)



Bros H.; Hauser A.; Paul F.; Niesner R.; Infante-Duarte C.
Assessing mitochondrial movement within neurons: manual versus automated tracking methods
Traffic 16 (8): 906-917 (2015-08)



Doss S.; Rinnenthal J.L.; Schmitz-Huebsch T.; Brandt A.U.; Papazoglou S.; Lux S.; Maul S.; Wuerfel J.; Endres M.; Klockgether T.; Minnerop M.; Paul F.
Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency
Journal of Neurology 262 (8): 1927-1935 (2015-08)



Paul F.; Ruprecht K.
Current immunotherapy of multiple sclerosis [Aktuelle Immuntherapie der Multiplen Sklerose]
Nervenarzt 86 (8): 1031-1044 (2015-08)



Melamed E.; Levy M.; Waters P.J.; Sato D.K.; Bennett J.L.; John G.R.; Hooper D.C.; Saiz A.; Bar-Or A.; Kim H.J.; Pandit L.; Leite M.I.; Asgari N.; Kissani N.; Hintzen R.; Marignier R.; Jarius S.; Marcelletti J.; Smith T.J.; Yeaman M.R.; Han M.H.
Update on biomarkers in neuromyelitis optica
Neurology Neuroimmunology & Neuroinflammation 2 (4): e134 (2015-07-23)



Veauthier C.; Gaede G.; Radbruch H.; Wernecke K.D.; Paul F.
Sleep disorders reduce health-related quality of life in multiple sclerosis (Nottingham Health Profile data in patients with multiple sclerosis)
International Journal of Molecular Sciences 16 (7): 16514-16528 (2015-07-21)



Bozin I.; Ge Y.; Kuchling J.; Dusek P.; Chawla S.; Harms L.; Ruprecht K.; Niendorf T.; Paul F.; Kister I.; Sinnecker T.; Wuerfel J.
Magnetic resonance phase alterations in multiple sclerosis patients with short and long disease duration
PLoS ONE 10 (7): e0128386 (2015-07-17)



Kister I.; Paul F.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Neurology 85 (2): 118-119 (2015-07-14)



Kremer S.; Renard F.; Achard S.; Lana-Peixoto M.A.; Palace J.; Asgari N.; Klawiter E.C.; Tenembaum S.N.; Banwell B.; Greenberg B.M.; Bennett J.L.; Levy M.; Villoslada P.; Saiz A.; Fujihara K.; Chan K.H.; Schippling S.; Paul F.; Kim H.J.; de Seze J.; Wuerfel J.T.
Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder
JAMA Neurology 72 (7): 815-822 (2015-07)



Janssen A.; Fiebiger S.; Bros H.; Hertwig L.; Romero-Suarez S.; Hamann I.; Chanvillard C.; Bellmann-Strobl J.; Paul F.; Millward J.M.; Infante-Duarte C.
Treatment of chronic experimental autoimmune encephalomyelitis with epigallocatechin-3-gallate and glatiramer acetate alters expression of heme-oxygenase-1
PLoS ONE 10 (6): e0130251 (2015-06-26)



Finke C.; Schlichting J.; Papazoglou S.; Scheel M.; Freing A.; Soemmer C.; Pech L.M.; Pajkert A.; Pfueller C.J.; Wuerfel J.T.; Ploner C.; Paul F.; Brandt A.U.
Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue
Multiple Sclerosis Journal 21 (7): 925-934 (2015-06)



Pandit L.; Asgari N.; Apiwattanakul M.; Palace J.; Paul F.; Leite M.I.; Kleiter I.; Chitnis T.
Demographic and clinical features of neuromyelitis optica: A review
Multiple Sclerosis Journal 21 (7): 845-853 (2015-06)



Doerr J.; Paul F.
The transition from first-line to second-line therapy in multiple sclerosis
Current Treatment Options in Neurology 17 (6): 354 (2015-06)



Ruprecht K.; Paul F.
Does Nrf2 help nerves to survive?
Neurology Neuroimmunology & Neuroinflammation 2 (3): e105 (2015-06)



Krumbholz M.; Hofstadt-van Oy U.; Angstwurm K.; Kleiter I.; Jarius S.; Paul F.; Aktas O.; Buchholz G.; Kern P.; Straube A.; Kuempfel T.
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
Journal of Neurology 262 (5): 1379-1384 (2015-05)



Bennett J.L.; de Seze J.; Lana-Peixoto M.; Palace J.; Waldman A.; Schippling S.; Tenembaum S.; Banwell B.; Greenberg B.; Levy M.; Fujihara K.; Chan K.H.; Kim H.J.; Asgari N.; Sato D.K.; Saiz A.; Wuerfel J.; Zimmermann H.; Green A.; Villoslada P.; Paul F.
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Multiple Sclerosis Journal 21 (6): 678-688 (2015-05)



Kim H.J.; Paul F.; Lana-Peixoto M.A.; Tenembaum S.; Asgari N.; Palace J.; Klawiter E.C.; Sato D.K.; de Seze J.; Wuerfel J.; Banwell B.L.; Villoslada P.; Saiz A.; Fujihara K.; Kim S.H.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update
Neurology 84 (11): 1165-1173 (2015-03-17)



Maehler A.; Steiniger J.; Bock M.; Klug L.; Parreidt N.; Lorenz M.; Zimmermann B.F.; Krannich A.; Paul F.; Boschmann M.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial
American Journal of Clinical Nutrition 101 (3): 487-495 (2015-03)



Schippling S.; Balk L.; Costello F.; Albrecht P.; Balcer L.; Calabresi P.; Frederiksen J.; Frohman E.; Green A.; Klistorner A.; Outteryck O.; Paul F.; Plant G.; Traber G.; Vermersch P.; Villoslada P.; Wolf S.; Petzold A.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
Multiple Sclerosis Journal 21 (2): 163-170 (2015-02)



Kotelnikova E.; Bernardo-Faura M.; Silberberg G.; Kiani N.A.; Messinis D.; Melas I.N.; Artigas L.; Schwartz E.; Mazo I.; Masso M.; Alexopoulos L.G.; Mas J.M.; Olsson T.; Tegner J.; Martin R.; Zamora A.; Paul F.; Saez-Rodriguez J.; Villoslada P.
Signaling networks in MS: a systems-based approach to developing new pharmacological therapies
Multiple Sclerosis Journal 21 (2): 138-146 (2015-02)



Sinnecker T.; Oberwahrenbrock T.; Metz I.; Zimmermann H.; Pfueller C.F.; Harms L.; Ruprecht K.; Ramien C.; Hahn K.; Brueck W.; Niendorf T.; Paul F.; Brandt A.U.; Doerr J.; Wuerfel J.
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning - an ultrahigh-field MR pilot study
European Radiology 25 (1): 122-131 (2015-01)



Huhn K.; Laemmer R.; Oberwahrenbrock T.; Laemmer A.; Waschbisch A.; Gosar D.; Brandt A.; Paul F.; Linker R.A.; Lee D.H.
Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage
European Journal of Neurology 22 (1): 86-92 (2015-01)



Hessler H.; Zimmermann H.; Oberwahrenbrock T.; Kadas E.M.; Mikolajczak J.; Brandt A.U.; Kauert A.; Paul F.; Schreiber S.J.
No evidence for retinal damage evolving from reduced retinal blood flow in carotid artery disease
BioMed Research International 2015: 604028 (2015)



Taylor B.; Moses H.; Paul F.; Suarez G.; Rametta M.
Treatment of multiple sclerosis - relationship between vitamin d and interferon {beta}-1b
European Neurological Review 10 (2): 124-130 (2015)



2014

Dusek P.; Tovar Martinez E.M.; Madai V.I.; Jech R.; Sobesky J.; Paul F.; Niendorf T.; Wuerfel J.; Schneider S.A.
7 Tesla MRI for brain iron quantification in homozygous and heterozygous PANK2 mutation carriers
Movement Disorders Clinical Practice 1 (4): 329-335 (2014-12)



Kuchling J.; Ramien C.; Bozin I.; Doerr J.; Harms L.; Rosche B.; Niendorf T.; Paul F.; Sinnecker T.; Wuerfel J.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study
Multiple Sclerosis Journal 20 (14): 1866-1871 (2014-12)



Scheel M.; Finke C.; Oberwahrenbrock T.; Freing A.; Pech L.M.; Schlichting J.; Soemmer C.; Wuerfel J.; Paul F.; Brandt A.U.
Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: a combined optical coherence tomography and diffusion tensor imaging study
Multiple Sclerosis Journal 20 (14): 1904-1907 (2014-12)



Lee D.H.; Heidecke H.; Schroeder A.; Paul F.; Wachter R.; Hoffmann R.; Ellrichmann G.; Dragun D.; Waschbisch A.; Stegbauer J.; Klotz P.; Gold R.; Dechend R.; Mueller D.N.; Saft C.; Linker R.A.
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease
Molecular Neurodegeneration 9 (1): 49 (2014-11-15)



Alten F.; Motte J.; Ewering C.; Osada N.; Clemens C.R.; Kadas E.M.; Eter N.; Paul F.; Marziniak M.
Multimodal retinal vessel analysis in CADASIL patients
PLoS ONE 9 (11): e112311 (2014-11-05)



Miyaji K.; Paul F.; Shahrizaila N.; Umapathi T.; Yuki N.
Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies?
Journal of Neuroimmunology 276 (1-2): 172-174 (2014-11)



Bros H.; Millward J.M.; Paul F.; Niesner R.; Infante-Duarte C.
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons
Experimental Neurology 261 (11): 127-135 (2014-11)



Lorenz M.; Paul F.; Moobed M.; Baumann G.; Zimmermann B.F.; Stangl K.; Stangl V.
The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo
European Journal of Pharmacology 740: 645-651 (2014-10-05)



Mueller K.; Kuchling J.; Doerr J.; Harms L.; Ruprecht K.; Niendorf T.; Wuerfel J.; Paul F.; Sinnecker T.
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T
Journal of Neurology 261 (10): 2032-2036 (2014-10)



Doss S.; Wandinger K.P.; Hyman B.T.; Panzer J.A.; Synofzik M.; Dickerson B.; Mollenhauer B.; Scherzer C.R.; Ivinson A.J.; Finke C.; Schoels L.; Mueller vom Hagen J.; Trenkwalder C.; Jahn H.; Hoeltje M.; Biswal B.B.; Harms L.; Ruprecht K.; Buchert R.; Hoeglinger G.U.; Oertel W.H.; Unger M.M.; Koertvelyessy P.; Bittner D.; Priller J.; Spruth E.J.; Paul F.; Meisel A.; Lynch D.R.; Dirnagl U.; Endres M.; Teegen B.; Probst C.; Komorowski L.; Stoecker W.; Dalmau J.; Pruess H.
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
Annals of Clinical and Translational Neurology 1 (10): 822-832 (2014-10)



Motte J.; Alten F.; Ewering C.; Osada N.; Kadas E.M.; Brandt A.U.; Oberwahrenbrock T.; Clemens C.R.; Eter N.; Paul F.; Marziniak M.
Vessel labeling in combined confocal scanning laser ophthalmoscopy and optical coherence tomography Images : criteria for blood vessel discrimination
PLoS ONE 9 (9): e102034 (2014-09-09)



Borisow N.; Paul F.; Doerr J.
Optimal management of multiple sclerosis during pregnancy: current perspectives
Degenerative Neurological and Neuromuscular Disease 4: 111-120 (2014-08-05)



Albrecht P.; Balk L.; Oberwahrenbrock T.; Petzold A.; Paul F.
Retinal segmentation to demonstrate hyperplasia in ataxia of charlevoix-saguenay: critique on study methodology and results
Investigative Ophthalmology & Visual Science 55 (8): 4728 (2014-08-04)



Roth N.M.; Saidha S.; Zimmermann H.; Brandt A.U.; Isensee J.; Benkhellouf-Rutkowska A.; Dornauer M.; Kuehn A.A.; Mueller T.; Calabresi P.A.; Paul F.
Photoreceptor layer thinning in idiopathic Parkinson's disease
Movement Disorders 29 (9): 1163-1170 (2014-08)



Petzold A.; Wattjes M.P.; Costello F.; Flores-Rivera J.; Fraser C.L.; Fujihara K.; Leavitt J.; Marignier R.; Paul F.; Schippling S.; Sindic C.; Villoslada P.; Weinshenker B.; Plant G.T.
The investigation of acute optic neuritis: a review and proposed protocol
Nature Reviews Neurology 10 (8): 447-458 (2014-08)



Brandt A.U.; Paul F.; Saidha S.
Reply to: Photoreceptor layer thinning in Parkinsonian syndromes
Movement Disorders 29 (9): 1222-1223 (2014-08)



Maehler A.; Steiniger J.; Endres M.; Paul F.; Boschmann M.; Doss S.
Increased catabolic state in spinocerebellar ataxia type 1 patients
Cerebellum 13 (4): 440-446 (2014-08)



Jarius S.; Paul F.; Fechner K.; Ruprecht K.; Kleiter I.; Franciotta D.; Ringelstein M.; Pache F.; Aktas O.; Wildemann B.
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate
Journal of Neuroinflammation 11 (1): 129 (2014-07-29)



Ruprecht K.; Wunderlich B.; Giess R.; Meyer P.; Loebel M.; Lenz K.; Hofmann J.; Rosche B.; Wengert O.; Paul F.; Reimer U.; Scheibenbogen C.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1
Journal of Neuroimmunology 272 (1-2): 56-61 (2014-07-15)



Brandt A.U.; Oberwahrenbrock T.; Kadas E.M.; Lagreze W.A.; Paul F.
Dynamic formation of macular microcysts independent of vitreous traction changes
Neurology 83 (1): 73-77 (2014-07-01)



Borisow N.; Paul F.; Ohlraun S.; Pach D.; Fischer F.; Doerr J.
Pregnancy in multiple sclerosis: a questionnaire study
PLoS ONE 9 (6): e99106 (2014-06-05)



Ringelstein M.; Metz I.; Ruprecht K.; Koch A.; Rappold J.; Ingwersen J.; Mathys C.; Jarius S.; Brueck W.; Hartung H.P.; Paul F.; Aktas O.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Multiple Sclerosis Journal 20 (7): 882-888 (2014-06)



Kremer L.; Mealy M.; Jacob A.; Nakashima I.; Cabre P.; Bigi S.; Paul F.; Jarius S.; Aktas O.; Elsone L.; Mutch K.; Levy M.; Takai Y.; Collongues N.; Banwell B.; Fujihara K.; de Seze J.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients
Multiple Sclerosis Journal 20 (7): 843-847 (2014-06)



Behrens J.; Pfueller C.; Mansow-Model S.; Otte K.; Paul F.; Brandt A.U.
Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test
Journal of Neuroengineering and Rehabilitation 11: 89 (2014-05-27)



Jarius S.; Wildemann B.; Paul F.
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
Clinical and Experimental Immunology 176 (2): 149-164 (2014-05)



Koepke S.; Kern S.; Ziemssen T.; Berghoff M.; Kleiter I.; Marziniak M.; Paul F.; Vettorazzi E.; Poettgen J.; Fischer K.; Kasper J.; Heesen C.
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial
Journal of Neurology Neurosurgery and Psychiatry 85 (4): 411-418 (2014-04)



Gaede G.; Hellweg R.; Zimmermann H.; Brandt A.U.; Doerr J.; Bellmann-Strobl J.; Zangen A.; Paul F.; Pfueller C.F.
Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers
Neuropsychobiology 69 (2): 112-119 (2014-04)



Kuchling J.; Sinnecker T.; Bozin I.; Doerr J.; Madai V.I.; Sobesky J.; Niendorf T.; Paul F.; Wuerfel J.
Ultrahochfeld-MRT im Kontext neurologischer Erkrankungen [Ultrahigh field MRI in context of neurological diseases]
Nervenarzt 85 (4): 445-458 (2014-04)



Ringelstein M.; Kleiter I.; Ayzenberg I.; Borisow N.; Paul F.; Ruprecht K.; Kraemer M.; Cohn E.; Wildemann B.; Jarius S.; Hartung H.P.; Aktas O.; Albrecht P.
Visual evoked potentials in neuromyelitis optica and its spectrum disorders
Multiple Sclerosis Journal 20 (5): 617-620 (2014-04)



Doss S.; Brandt A.U.; Oberwahrenbrock T.; Endres M.; Paul F.; Rinnenthal J.L.
Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1
Cerebellum 13 (2): 199-206 (2014-04)



Jarius S.; Kleffner I.; Doerr J.M.; Sastre-Garriga J.; Illes Z.; Eggenberger E.; Chalk C.; Ringelstein M.; Aktas O.; Montalban X.; Fechner K.; Stoecker W.; Ringelstein E.B.; Paul F.; Wildemann B.
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study
Journal of Neuroinflammation 11: 46 (2014-03-08)



Keller A.; Leidinger P.; Steinmeyer F.; Staehler C.; Franke A.; Hemmrich-Stanisak G.; Kappel A.; Wright I.; Doerr J.; Paul F.; Diem R.; Tocariu-Krick B.; Meder B.; Backes C.; Meese E.; Ruprecht K.
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing
Multiple Sclerosis Journal 20 (3): 295-303 (2014-03)



Schinzel J.; Zimmermann H.; Paul F.; Ruprecht K.; Hahn K.; Brandt A.U.; Doerr J.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis
BMC Neurology 14: 31 (2014-02-20)



Collongues N.; Marignier R.; Jacob A.; Leite M.; Siva A.; Paul F.; Zephir H.; Akman-Demir G.; Elsone L.; Jarius S.; Papeix C.; Mutch K.; Saip S.; Wildemann B.; Kitley J.; Karabudak R.; Aktas O.; Kuscu D.; Altintas A.; Palace J.; Confavreux C.; De Seze J.
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
Multiple Sclerosis Journal 20 (8): 1086-1094 (2014)



Veauthier C.; Paul F.
Sleep disorders in multiple sclerosis and their relationship to fatigue
Sleep Medicine 15 (1): 5-14 (2014-01)



Trebst C.; Jarius S.; Berthele A.; Paul F.; Schippling S.; Wildemann B.; Borisow N.; Kleiter I.; Aktas O.; Kuempfel T.
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Journal of Neurology 261 (1): 1-16 (2014-01)



2013

Oberwahrenbrock T.; Ringelstein M.; Jentschke S.; Deuschle K.; Klumbies K.; Bellmann-Strobl J.; Harmel J.; Ruprecht K.; Schippling S.; Hartung H.P.; Aktas O.; Brandt A.U.; Paul F.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
Multiple Sclerosis Journal 19 (14): 1887-1895 (2013-12)



Wieder L.; Gaede G.; Pech L.M.; Zimmermann H.; Wernecke K.D.; Doerr J.M.; Bellmann-Strobl J.; Paul F.; Brandt A.U.
Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study
BMC Neurology 13: 167 (2013-11-08)



Lipp A.; Trbojevic R.; Paul F.; Fehlner A.; Hirsch S.; Scheel M.; Noack C.; Braun J.; Sack I.
Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease
NeuroImage: Clinical 3: 381-387 (2013-09-20)



Fiebiger S.M.; Bros H.; Grobosch T.; Janssen A.; Chanvillard C.; Paul F.; Doerr J.; Millward J.M.; Infante-Duarte C.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse
Journal of Neuroimmunology 262 (1-2): 66-71 (2013-09-15)



Veauthier C.; Gaede G.; Radbruch H.; Gottschalk S.; Wernecke K.D.; Paul F.
Treatment of sleep disorders may improve fatigue in multiple sclerosis
Clinical Neurology and Neurosurgery 115 (9): 1826-1830 (2013-09)



Balint B.; Haas J.; Schwarz A.; Jarius S.; Fuerwentsches A.; Engelhardt K.; Bussmann C.; Ebinger F.; Fritzsching B.; Paul F.; Seidel U.; Vlaho S.; Huppke P.; Gaertner J.; Wildemann B.
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients
Neurology 81 (9): 784-792 (2013-08-27)



Lepore S.; Waiczies H.; Hentschel J.; Ji Y.; Skodowski J.; Pohlmann A.; Millward J.M.; Paul F.; Wuerfel J.; Niendorf T.; Waiczies S.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis
PLoS ONE 8 (8): e72841 (2013-08-22)



Derkow K.; Bauer J.M.J.; Hecker M.; Paap B.K.; Thamilarasan M.; Koczan D.; Schott E.; Deuschle K.; Bellmann-Strobl J.; Paul F.; Zettl U.K.; Ruprecht K.; Lehnardt S.
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-{beta} includes upregulation of TLR7 in plasmacytoid dendritic cells
PLoS ONE 8 (8): e70626 (2013-08-12)



Kaufhold F.; Zimmermann H.; Schneider E.; Ruprecht K.; Paul F.; Oberwahrenbrock T.; Brandt A.U.
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis
PLoS ONE 8 (8): e71145 (2013-08-06)



Finke C.; Kopp U.A.; Scheel M.; Pech L.M.; Soemmer C.; Schlichting J.; Leypoldt F.; Brandt A.U.; Wuerfel J.; Probst C.; Ploner C.J.; Pruess H.; Paul F.
Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis
Annals of Neurology 74 (2): 284-296 (2013-08)



Deuschle K.; Hofmann J.; Otto C.; Bellmann-Strobl J.; Scherner O.; Klumbies K.; Schneider E.; Broddack J.; Paul F.; Ruprecht K.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Multiple Sclerosis Journal 19 (9): 1242-1243 (2013-08)



Roth N.M.; Saidha S.; Zimmermann H.; Brandt A.U.; Oberwahrenbrock T.; Maragakis N.J.; Tumani H.; Ludolph A.C.; Meyer T.; Calabresi P.A.; Paul F.
Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis
European Journal of Neurology 20 (8): 1170-1176 (2013-08)



Leidinger P.; Backes C.; Deutscher S.; Schmitt K.; Mueller S.C.; Frese K.; Haas J.; Ruprecht K.; Paul F.; Staehler C.; Lang C.J.G.; Meder B.; Bartfai T.; Meese E.; Keller A.
A blood based 12-miRNA signature of Alzheimer disease patients
Genome Biology 14 (7): R78 (2013-07-29)



Schneider E.; Zimmermann H.; Oberwahrenbrock T.; Kaufhold F.; Kadas E.M.; Petzold A.; Bilger F.; Borisow N.; Jarius S.; Wildemann B.; Ruprecht K.; Brandt A.U.; Paul F.
Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis
PLoS ONE 8 (6): e66151 (2013-06-21)



Doerr J.; Krautwald S.; Wildemann B.; Jarius S.; Ringelstein M.; Duning T.; Aktas O.; Ringelstein E.B.; Paul F.; Kleffner I.
Characteristics of Susac syndrome: a review of all reported cases
Nature Reviews Neurology 9 (6): 307-316 (2013-06)



Young K.L.; Brandt A.U.; Petzold A.; Reitz L.Y.; Lintze F.; Paul F.; Martin R.; Schippling S.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis
European Journal of Neurology 20 (5): 803-811 (2013-05)



Valdueza J.M.; Doepp F.; Schreiber S.J.; van Oosten B.W.; Schmierer K.; Paul F.; Wattjes M.P.
What went wrong? The flawed concept of cerebrospinal venous insufficiency
Journal of Cerebral Blood Flow and Metabolism 33 (5): 657-668 (2013-05)



Rosche B.; Wernecke K.D.; Ohlraun S.; Doerr J.M.; Paul F.
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
Trials 14: 112 (2013-04-25)



Lill C.M.; Guenther-Kunkel K.; Hoch H.; Paul F.; Grond-Ginsbach C.; Hausser I.; Zipp F.
Bilateral vertebral artery dissection, agenesis of both ICAs, and connective tissue aberrations
Neurology 80 (15): 1442-1443 (2013-04-09)



Borisow N.; Pruess H.; Paul F.
Therapieoptionen bei immunvermittelten Enzephalomyelitiden [Therapeutic options for autoimmune encephalomyelitis]
Nervenarzt 84 (4): 461-465 (2013-04)



Bock M.; Paul F.; Doerr J.
Diagnostik und Verlaufsbeurteilung der Multiplen Sklerose: Stellenwert der optischen Kohaerenztomographie [Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography]
Nervenarzt 84 (4): 483-492 (2013-04)



Zimmermann H.; Freing A.; Kaufhold F.; Gaede G.; Bohn E.; Bock M.; Oberwahrenbrock T.; Young K.L.; Doerr J.; Wuerfel J.T.; Schippling S.; Paul F.; Brandt A.U.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations
Multiple Sclerosis Journal 19 (4): 443-450 (2013-04)



Wildemann B.; Jarius S.; Paul F.
Neuromyelitis optica
Nervenarzt 84 (4): 436-441 (2013-04)



Conradi S.; Malzahn U.; Paul F.; Quill S.; Harms L.; Then Bergh F.; Ditzenbach A.; Georgi T.; Heuschmann P.; Rosche B.
Breastfeeding is associated with lower risk for multiple sclerosis
Multiple Sclerosis Journal 19 (5): 553-558 (2013-04)



Sinnecker T.; Bozin I.; Doerr J.; Pfueller C.F.; Harms L.; Niendorf T.; Brandt A.U.; Paul F.; Wuerfel J.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study
Multiple Sclerosis Journal 19 (3): 316-325 (2013-03)



Veauthier C.; Blau A.; Paul F.
'Obstructive sleep apnea is associated with fatigue in multiple sclerosis' by Kaminska et al
Multiple Sclerosis Journal 19 (3): 372-373 (2013-03)



Maehler A.; Mandel S.; Lorenz M.; Ruegg U.; Wanker E.E.; Boschmann M.; Paul F.
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases
EPMA Journal 4 (1): 5 (2013-02-18)



Doering A.; Paul F.; Doerr J.
Vitamin D und Multiple Sklerose: Der Stellenwert fuer das Erkrankungsrisiko und die Behandlung [Vitamin D and multiple sclerosis: the role for risk of disease and treatment]
Nervenarzt 84 (2): 173-189 (2013-02)



Doerr J.; Doering A.; Paul F.
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
EPMA Journal 4: 4 (2013-01-29)



Borisow N.; Meyer T.; Paul F.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
BMJ Case Reports 2013: (2013-01-23)



Hamann I.; Doerr J.; Glumm R.; Chanvillard C.; Janssen A.; Millward J.M.; Paul F.; Ransohoff R.M.; Infante-Duarte C.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
Journal of Neuroimmunology 254 (1-2): 165-169 (2013-01-15)



2012

Finke C.; Pech L.M.; Soemmer C.; Schlichting J.; Stricker S.; Endres M.; Ostendorf F.; Ploner C.J.; Brandt A.U.; Paul F.
Dynamics of saccade parameters in multiple sclerosis patients with fatigue
Journal of Neurology 259 (12): 2656-2663 (2012-12)



Paul F.; Veauthier C.
Fatigue and sleep disorders in multiple sclerosis: is obstructive sleep apnea a link?
Sleep & Breathing 16 (4): 949-950 (2012-12)



Riek K.; Millward J.M.; Hamann I.; Mueller S.; Pfueller C.F.; Paul F.; Braun J.; Infante-Duarte C.; Sack I.
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis
NeuroImage: Clinical 1 (1): 81-90 (2012-11-12)



Wuerfel J.; Sinnecker T.; Ringelstein E.B.; Jarius S.; Schwindt W.; Niendorf T.; Paul F.; Kleffner I.; Doerr J.
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis
Multiple Sclerosis 18 (11): 1592-1599 (2012-11)



Hackmack K.; Weygandt M.; Wuerfel J.; Pfueller C.F.; Bellmann-Strobl J.; Paul F.; Haynes J.D.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Journal of Neurology 259 (10): 2151-2160 (2012-10)



Jarius S.; Franciotta D.; Paul F.; Bergamaschi R.; Rommer P.S.; Ruprecht K.; Ringelstein M.; Aktas O.; Kristoferitsch W.; Wildemann B.
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry
Journal of the Neurological Sciences 320 (1-2): 32-37 (2012-09-15)



Maehler A.; Steiniger J.; Bock M.; Brandt A.U.; Haas V.; Boschmann M.; Paul F.
Is metabolic flexibility altered in multiple sclerosis patients?
PLoS ONE 7 (8): e43675 (2012-08-28)



Sinnecker T.; Doerr J.; Pfueller C.F.; Harms L.; Ruprecht K.; Jarius S.; Brueck W.; Niendorf T.; Wuerfel J.; Paul F.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Neurology 79 (7): 708-714 (2012-08-14)



Jarius S.; Paul F.; Franciotta D.; de Seze J.; Muench C.; Salvetti M.; Ruprecht K.; Liebetrau M.; Wandinger K.; Akman-Demir G.; Melms A.; Kristoferitsch W.; Wildemann B.
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature
Multiple Sclerosis Journal 18 (8): 1135-1143 (2012-08)



Hackmack K.; Paul F.; Weygandt M.; Allefeld C.; Haynes J.D.
Multi-scale classification of disease using structural MRI and wavelet transform
NeuroImage 62 (1): 48-58 (2012-08-01)



Oberwahrenbrock T.; Schippling S.; Ringelstein M.; Kaufhold F.; Zimmermann H.; Keser N.; Young K.L.; Harmel J.; Hartung H.P.; Martin R.; Paul F.; Aktas O.; Brandt A.U.
Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography
Multiple Sclerosis International 2012: 530305 (2012-07-25)



Chanvillard C.; Millward J.M.; Lozano M.; Hamann I.; Paul F.; Zipp F.; Doerr J.; Infante-Duarte C.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis
PLoS ONE 7 (6): e39625 (2012-06-29)



Schinzel J.; Schwarzlose L.; Dietze H.; Bartusch K.; Weiss S.; Ohlraun S.; Paul F.; Doerr J.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial
Trials 13: 94 (2012-06-28)



Borisow N.; Doering A.; Pfueller C.F.; Paul F.; Doerr J.; Hellwig K.
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
EPMA Journal 3 (1): 9 (2012-06-22)



Brandt A.U.; Zimmermann H.; Kaufhold F.; Promesberger J.; Schippling S.; Finis D.; Aktas O.; Geis C.; Ringelstein M.; Ringelstein E.B.; Hartung H.P.; Paul F.; Kleffner I.; Doerr J.
Patterns of retinal damage facilitate differential diagnosis between susac syndrome and MS
PLoS ONE 7 (6): e38741 (2012-06-11)



Sinnecker T.; Mittelstaedt P.; Doerr J.; Pfueller C.F.; Harms L.; Niendorf T.; Paul F.; Wuerfel J.
Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study
Archives of Neurology 69 (6): 739-745 (2012-06)



Paul F.
Immunmodulatorische Therapie mit Interferon {beta}-1b bei klinisch isoliertem Syndrom [Immunomodulatory therapy with interferon {beta}-1b in clinically isolated syndrome
Aktuelle Neurologie 39 (S1): S16-S18 (2012-05-22)



Kaufhold F.; Kadas E.M.; Schmidt C.; Kunte H.; Hoffmann J.; Zimmermann H.; Oberwahrenbrock T.; Harms L.; Polthier K.; Brandt A.U.; Paul F.
Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT
PLoS ONE 7 (5): e36965 (2012-05-15)



Stroet A.; Hemmelmann C.; Starck M.; Zettl U.; Doerr J.; Paul F.; Flachenecker P.; Fleischer V.; Zipp F.; Nueckel H.; Kieseier B.C.; Ziegler A.; Gold R.; Chan A.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
Therapeutic Advances in Neurological Disorders 5 (2): 75-79 (2012-03)



Doerr J.; Ohlraun S.; Skarabis H.; Paul F.
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Trials 13: 15 (2012-02-08)



Wildemann B.; Jarius S.; Paul F.
Neuromyelitis optica
Aktuelle Neurologie 39 (1): 33-41 (2012-02)



Veauthier C.; Paul F.
Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Multiple Sclerosis 18 (2): 248-249 (2012-02)



Kleiter I.; Hellwig K.; Berthele A.; Kuempfel T.; Linker R.A.; Hartung H.P.; Paul F.; Aktas O.
Failure of natalizumab to prevent relapses in neuromyelitis optica
Archives of Neurology 69 (2): 239-245 (2012-02)



Streitberger K.J.; Sack I.; Krefting D.; Pfueller C.; Braun J.; Paul F.; Wuerfel J.
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis
PLoS ONE 7 (1): e29888 (2012-01-20)



Jarius S.; Ruprecht K.; Wildemann B.; Kuempfel T.; Ringelstein M.; Geis C.; Kleiter I.; Kleinschnitz C.; Berthele A.; Brettschneider J.; Hellwig K.; Hemmer B.; Linker R.A.; Lauda F.; Mayer C.A.; Tumani H.; Melms A.; Trebst C.; Stangel M.; Marziniak M.; Hoffmann F.; Schippling S.; Faiss J.H.; Neuhaus O.; Ettrich B.; Zentner C.; Guthke K.; Hofstadt-van Oy U.; Reuss R.; Pellkofer H.; Ziemann U.; Kern P.; Wandinger K.P.; Bergh F.T.; Boettcher T.; Langel S.; Liebetrau M.; Rommer P.S.; Niehaus S.; Muench C.; Winkelmann A.; Zettl U U.K.; Metz I.; Veauthier C.; Sieb J.P.; Wilke C.; Hartung H.P.; Aktas O.; Paul F.
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Journal of Neuroinflammation 9: 14 (2012-01-19)



Bock M.; Brandt A.U.; Kuchenbecker J.; Doerr J.; Pfueller C.F.; Weinges-Evers N.; Gaede G.; Zimmermann H.; Bellmann-Strobl J.; Ohlraun S.; Zipp F.; Paul F.
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis
British Journal of Ophthalmology 96 (1): 62-67 (2012-01)



2011

Doering A.; Pfueller C.F.; Paul F.; Doerr J.
Exercise in multiple sclerosis - an integral component of disease management
EPMA Journal 3: 2 (2011-12-24)



Doepp F.; Wuerfel J.T.; Pfueller C.F.; Valdueza J.M.; Petersen D.; Paul F.; Schreiber S.J.
Venous drainage in multiple sclerosis: A combined MRI and ultrasound study
Neurology 77 (19): 1745-1751 (2011-11-08)



Brandt A.U.; Oberwahrenbrock T.; Ringelstein M.; Young K.L.; Tiede M.; Hartung H.P.; Martin R.; Aktas O.; Paul F.; Schippling S.
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Brain 134 (Pt 11): e193 (2011-11)



Doepp F.; Paul F.; Valdueza J.M.; Schreiber S.J.
Chronisch venoese Insuffizienz als Ursache der Multiplen Sklerose? [Is chronic cerebrospinal venous insufficiency a cause of multiple sclerosis?]
Aktuelle Neurologie 38 (7): 332-338 (2011-10-24)



Conradi S.; Malzahn U.; Schroeter F.; Paul F.; Quill S.; Spruth E.; Harms L.; Then Bergh F.; Ditzenbach A.; Georgi T.; Heuschmann P.; Rosche B.
Environmental factors in early childhood are associated with multiple sclerosis: a case-control study
BMC Neurology 11: 123 (2011-10-06)



Doerr J.; Jarius S.; Wildemann B.; Ringelstein E.B.; Schwindt W.; Deppe M.; Wandinger K.P.; Promesberger J.; Paul F.; Kleffner I.
Susac-Syndrom: Eine interdisziplinaere Herausforderung [Susac syndrome: an interdisciplinary challenge]
Nervenarzt 82 (10): 1250-1263 (2011-10)



Sack I.; Streitberger K.J.; Krefting D.; Paul F.; Braun J.
The influence of physiological aging and atrophy on brain viscoelastic properties in humans
PLoS ONE 6 (9): e23451 (2011-09-12)



Jarius S.; Jacobi C.; de Seze J.; Zephir H.; Paul F.; Franciotta D.; Rommer P.; Mader S.; Kleiter I.; Reindl M.; Akman-Demir G.; Seifert-Held T.; Kristoferitsch W.; Melms A.; Wandinger K.P.; Wildemann B.
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders
Multiple Sclerosis Journal 17 (9): 1067-1073 (2011-09)



Stricker S.; Oberwahrenbrock T.; Zimmermann H.; Schroeter J.; Endres M.; Brandt A.U.; Paul F.
Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1
PLoS ONE 6 (7): e23024 (2011-07-29)



Waiczies H.; Lepore S.; Janitzek N.; Hagen U.; Seifert F.; Ittermann B.; Purfuerst B.; Pezzutto A.; Paul F.; Niendorf T.; Waiczies S.
Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells
PLoS ONE 6 (7): e21981 (2011-07-19)



Jarius S.; Paul F.; Franciotta D.; Ruprecht K.; Ringelstein M.; Bergamaschi R.; Rommer P.; Kleiter I.; Stich O.; Reuss R.; Rauer S.; Zettl U.K.; Wandinger K.P.; Melms A.; Aktas O.; Kristoferitsch W.; Wildemann B.
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures
Journal of the Neurological Sciences 306 (1-2): 82-90 (2011-07-15)



Weygandt M.; Hackmack K.; Pfueller C.; Bellmann-Strobl J.; Paul F.; Zipp F.; Haynes J.D.
MRI pattern recognition in multiple sclerosis normal-appearing brain areas
PLoS ONE 6 (6): e21138 (2011-06-17)



Trebst C.; Berthele A.; Jarius S.; Kuempfel T.; Schippling S.; Wildemann B.; Wilke C.
Diagnostik und Therapie der Neuromyelitis optica: Konsensusempfehlungen der Neuromyelitis optica Studiengruppe [Diagnosis and treatment of neuromyelitis optica: Consensus recommendations of the Neuromyelitis Optica Study Group]
Nervenarzt 82 (6): 768-777 (2011-06)



Veauthier C.; Radbruch H.; Gaede G.; Pfueller C.; Doerr J.; Bellmann-Strobl J.; Wernecke K.D.; Zipp F.; Paul F.; Sieb J.
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study
Multiple Sclerosis 17 (5): 613-622 (2011-05)



Doerr J.; Wernecke K.D.; Bock M.; Gaede G.; Wuerfel J.T.; Pfueller C.F.; Bellmann-Strobl J.; Freing A.; Brandt A.U.; Paul F.
Association of retinal and macular damage with brain atrophy in multiple sclerosis
PLoS ONE 6 (4): e18132 (2011-04-08)



Pfueller C.F.; Brandt A.U.; Schubert F.; Bock M.; Walaszek B.; Waiczies H.; Schwenteck T.; Doerr J.; Bellmann-Strobl J.; Mohr C.; Weinges-Evers N.; Ittermann B.; Wuerfel J.T.; Paul F.
Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis
PLoS ONE 6 (4): e18019 (2011-04-06)



Pfueller C.F.; Paul F.
Imaging the visual pathway in neuromyelitis optica
Multiple Sclerosis International 2011: 869814 (2011-03-16)



Woelbert M.; Brandt A.U.; Paul F.; Schippling S.
Optische Kohaerenztomografie in der Multiplen Sklerose
Nervenheilkunde 30 (7): 493-497 (2011)



Paul F.
Multiple Sklerose – klinisch relevante Themen
Nervenheilkunde 30 (7): 461-462 (2011)



2010

Hohn O.; Strohschein K.; Brandt A.U.; Seeher S.; Klein S.; Kurth R.; Paul F.; Meisel C.; Scheibenbogen C.; Bannert N.
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro
PLoS ONE 5 (12): e15632 (2010-12-22)



Doering A.; Paul F.
The German healthcare system
EPMA Journal 1 (4): 535-547 (2010-12)



Jarius S.; Frederikson J.; Waters P.; Paul F.; Akman-Demir G.; Marignier R.; Franciotta D.; Ruprecht K.; Kuenz B.; Rommer P.; Kristoferitsch W.; Wildemann B.; Vincent A.
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Journal of the Neurological Sciences 298 (1-2): 158-162 (2010-11-15)



Sellner J.; Cepok S.; Kalluri S.R.; Nestler A.; Kleiter I.; Kuempfel T.; Linker R.; Melms A.; Menge T.; Tumani H.; Paul F.; Hemmer B.; Berthele A.
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses
Neurochemistry International 57 (6): 662-667 (2010-11)



Paul F.; Doerr J.M.
Flupirtine add-on to IFN {beta}-1b in RRMS
Nervenarzt 81 (Suppl 1): 28-29 (2010-10)



Bock M.; Brandt A.U.; Doerr J.; Kraft H.; Weinges-Evers N.; Gaede G.; Pfueller C.F.; Herges K.; Radbruch H.; Ohlraun S.; Bellmann-Strobl J.; Kuchenbecker J.; Zipp F.; Paul F.
Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients
Clinical Neurology and Neurosurgery 112 (8): 647-652 (2010-10)



Jarius S.; Franciotta D.; Paul F.; Ruprecht K.; Bergamaschi R.; Rommer P.S.; Reuss R.; Probst C.; Kristoferitsch W.; Wandinger K.P.; Wildemann B.
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Journal of Neuroinflammation 7: 52 (2010-09-08)



Weinges-Evers N.; Brandt A.U.; Bock M.; Pfueller C.F.; Doerr J.; Bellmann-Strobl J.; Scherer P.; Urbanek C.; Boers C.; Ohlraun S.; Zipp F.; Paul F.
Correlation of self-assessed fatigue and alertness in multiple sclerosis
Multiple Sclerosis 16 (9): 1134-1140 (2010-09)



Doepp F.; Paul F.; Valdueza J.M.; Schmierer K.; Schreiber S.J.
No cerebrocervical venous congestion in patients with multiple sclerosis
Annals of Neurology 68 (2): 173-183 (2010-08)



Bock M.; Brandt A.U.; Doerr J.; Pfueller C.F.; Ohlraun S.; Zipp F.; Paul F.
Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study
Multiple Sclerosis 16 (7): 893-896 (2010-07)



Wuerfel J.; Paul F.; Beierbach B.; Hamhaber U.; Klatt D.; Papazoglou S.; Zipp F.; Martus P.; Braun J.; Sack I.
MR-elastography reveals degradation of tissue integrity in multiple sclerosis
NeuroImage 49 (3): 2520-2525 (2010-02-01)



Urbanek C.; Weinges-Evers N.; Bellmann-Strobl J.; Bock M.; Doerr J.; Hahn E.; Neuhaus A.H.; Opgen-Rhein C.; Ta T.M.; Herges K.; Pfueller C.F.; Radbruch H.; Wernecke K.D.; Ohlraun S.; Zipp F.; Dettling M.; Paul F.
Attention Network Test reveals alerting network dysfunction in multiple sclerosis
Multiple Sclerosis 16 (1): 93-99 (2010-01)



2009

Bellmann-Strobl J.; Wuerfel J.; Aktas O.; Doerr J.; Wernecke K.D.; Zipp F.; Paul F.
Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis
Neurology 73 (20): 1624-1627 (2009-11-17)



2007

Paul F.; Veauthier C.; Fritz G.; Lehmann T.N.; Aktas O.; Zipp F.; Meencke H.J.
Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery
Seizure 16 (6): 479-484 (2007-09)